1.Fibroma of tendon sheath: a clinicopathological and genetic analysis of 134 cases.
Jian CUI ; Ya LU ; Yan QIU ; Xin HE ; Min CHEN ; Hong Ying ZHANG
Chinese Journal of Pathology 2023;52(4):364-369
Objective: To investigate the clinicopathological features, immunophenotypes and molecular genetics of fibroma of tendon sheath (FTS). Methods: One hundred and thirty-four cases of FTS or tenosynovial fibroma diagnosed in the Department of Pathology, West China Hospital, Sichuan University, Chengdu, China from January 2008 to April 2019 were selected. The clinical and histologic features of these cases were retrospectively reviewed. Immunohistochemistry, fluorescence in situ hybridization (FISH) and reverse transcription-polymerase chain reaction (RT-PCR) were performed on the above cases. Results: There were a total of 134 cases of FTS, including 67 males and 67 females. The patients' median age was 38 years (ranged from 2 to 85 years). The median tumor size was 1.8 cm (ranged from 0.1 to 6.8 cm). The most common site was the upper extremity (76/134, 57%). Follow-up data was available in 28 cases and there was no detectable recurrence. Classic FTS (114 cases) were well-defined and hypocellular. A few spindle-shaped fibroblasts were scattered in the dense collagenous sclerotic stroma. Characteristically elongated slit-like spaces or thin-walled vessels were observed. Most of cellular FTSs (20 cases) were well-defined and the area with increased cellularity of the spindle cells coexisted with classic FTS. There were occasional mitotic figures, but no atypical mitotic figures. Immunohistochemistry was performed in 8 cases of classic FTS and most cases were positive for SMA (5/8). Immunohistochemistry was also performed in 13 cases of cellular FTS and showed 100% positive rate for SMA. FISH was conducted on 20 cases of cellular FTS and 32 cases of classical FTS. USP6 gene rearrangement was found in 11/20 of cellular FTS. Among 12 cases of CFTS with nodular fasciitis (NF)-like morphological feature, 7 cases showed USP6 gene rearrangement. The rearrangement proportion of USP6 gene in cellular FTS without NF-like morphological features was 4/8. By contrast, 3% (1/32) of the classic FTS showed USP6 gene rearrangement. RT-PCR was performed in those cases with detected USP6 gene rearrangement and sufficient tissue samples for RT-PCR. The MYH9-USP6 fusion gene was detected in 1 case (1/8) of the cellular FTSs, while no target fusion partner was detected in the classic FTS. Conclusions: FTS is a relatively rare benign fibroblastic or myofibroblastic tumor. Our study and recent literature find that some of the classic FTS also show USP6 gene rearrangements, suggesting that classical FTS and cellular FTS are likely to be at different stages of the same disease (spectrum). FISH for USP6 gene rearrangement may be used as an important auxiliary diagnostic tool in distinguishing FTS from other tumors.
Male
;
Female
;
Humans
;
Gene Rearrangement
;
In Situ Hybridization, Fluorescence
;
Retrospective Studies
;
Fibroma/pathology*
;
Fasciitis/genetics*
;
Ubiquitin Thiolesterase
;
Tendons/pathology*
3.Clinical and pathological features and differential diagnosis of fibro-osseous tumors and dysplasias.
Ce SHI ; Zhi Min LI ; Hong Chen SUN
Chinese Journal of Stomatology 2023;58(2):124-130
Fibro-osseous lesions is a class of diseases with obvious similarities in clinical manifestations and pathological features, which has been attracting the attention of clinicians and pathologists. The latest WHO 2022 Classification (5th edition) included six of these diseases (cemento-osseous dysplasia, segmental odontomaxillary dysplasia, fibrous dysplasia, juvenile trabecular ossifying fibroma, psammomatoid ossifying fibroma and familial gigantiform cementoma) in the " fibro-osseous tumours and dysplasias ", and put forward new ideas on the diagnosis and treatment of these diseases. According to the latest WHO 2022 Classification (5th edition), the clinical and pathological features, diagnosis and differential diagnosis of these six diseases were described.
Humans
;
Fibroma, Ossifying/pathology*
;
Diagnosis, Differential
;
Cementoma/pathology*
;
Jaw Neoplasms
;
Facial Bones
7.Clinical laboratory features of Meigs' syndrome: a retrospective study from 2009 to 2018.
Wenwen SHANG ; Lei WU ; Rui XU ; Xian CHEN ; Shasha YAO ; Peijun HUANG ; Fang WANG
Frontiers of Medicine 2021;15(1):116-124
Meigs' syndrome (MS), a rare complication of benign ovarian tumors, is easily misdiagnosed as ovarian cancer (OC). We retrospectively reviewed the clinical laboratory data of patients diagnosed with MS from 2009 to 2018. Serum carbohydrate antigen 125 and HE4 levels were higher in the MS group than in the ovarian thecoma-fibroma (OTF) and healthy control groups (all P < 0.05). However, the serum HE4 levels were lower in the MS group than in the OC group (P < 0.001). A routine blood test showed that the absolute counts and percentages of lymphocytes were significantly lower in the MS group than in the OTF and control groups (all P < 0.05). However, these variables were higher in the MS group than in the OC group (both P < 0.05). The neutrophil-to-lymphocyte ratio (NLR) was also significantly lower, whereas the lymphocyte-to-monocyte ratio was higher in the MS group than in the OC group (both P < 0.05). The NLR, platelet-to-lymphocyte ratio, and systemic immune index were significantly higher in the MS group than in the OTF and control groups (all P < 0.05). The hypoxia-inducible factor-1 mRNA levels were also significantly higher, whereas the glucose transporter 1, lactate dehydrogenase, and enolase 1 mRNA levels were lower in peripheral CD4
Carcinoma, Ovarian Epithelial
;
Female
;
Fibroma
;
Humans
;
Laboratories
;
Meigs Syndrome/diagnosis*
;
Ovarian Neoplasms
;
Retrospective Studies
8.Copy number alteration profiling facilitates differential diagnosis between ossifying fibroma and fibrous dysplasia of the jaws.
Ming MA ; Lu LIU ; Ruirui SHI ; Jianyun ZHANG ; Xiaotian LI ; Xuefen LI ; Jiaying BAI ; Jianbin WANG ; Yanyi HUANG ; Tiejun LI
International Journal of Oral Science 2021;13(1):21-21
Ossifying fibroma (OF) and fibrous dysplasia (FD) are two fibro-osseous lesions with overlapping clinicopathological features, making diagnosis challenging. In this study, we applied a whole-genome shallow sequencing approach to facilitate differential diagnosis via precise profiling of copy number alterations (CNAs) using minute amounts of DNA extracted from morphologically correlated microdissected tissue samples. Freshly frozen tissue specimens from OF (n = 29) and FD (n = 28) patients were obtained for analysis. Lesion fibrous tissues and surrounding normal tissues were obtained by laser capture microdissection (LCM), with ~30-50 cells (5 000-10 000 µm
DNA Copy Number Variations
;
Diagnosis, Differential
;
Fibroma, Ossifying/genetics*
;
Fibrous Dysplasia of Bone/genetics*
;
Galactosyltransferases
;
Humans
;
Jaw
;
Neoplasm Recurrence, Local
;
Nuclear Proteins
10.Clinicopathological and genetic findings of infantile nodular fasciitis.
Yan QIU ; Xue HU ; Xin HE ; Wen-Jing ZENG ; Hong-Ying ZHANG
Chinese Medical Journal 2021;134(22):2768-2770

Result Analysis
Print
Save
E-mail